Oncotelic and Sapu Nano Announce DeciparticleTM Led Biomarker Framework Identifying Tumors Most Likely to Respond to IV Sapu003, an Intravenous Everolimus Nanomedicine
AGOURA HILLS, Calif., Dec. 04, 2025 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc.…
Bybit x FXStreet TradFi Report: Japan’s Historic Leadership Shift Sparks Nikkei Rally and Yen Weakness
DUBAI, UAE , Oct. 10, 2025 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency…
DoubleLine Foresees Further Treasury Yield Curve Steepening, Risk of Elevated Term Premium
TAMPA, Fla., Oct. 3, 2025 /PRNewswire/ -- The U.S. Treasury yield curve, DoubleLine Global…
Strong Lamborghini SC63 pace goes unrewarded in the Battle on the Bricks at Indianapolis
#63 pairing of Mortara-Grosjean finish 10th in penultimate round of the year…
EADV Congress 2025: Atopic eczema linked to significantly higher risk of suicidal thoughts
PARIS, Sept. 17, 2025 /PRNewswire/ -- A new international study presented today…
Huion Launches 2025 Back-to-School Deals: Promotions for Creative Tools for Students & Teachers
LOS ANGELES, Aug. 15, 2025 /PRNewswire/ -- With August here, the Back-to-School…
Cornerstone VR Sponsors Muay Thai Athlete Gene Smith to Support Youth Empowerment and Combat Knife Crime
Tuesday 8 July, 2025 According to the Youth Endowment Fund’s Children, Violence…
AB Science: Masitinib receives FDA and EMA authorization for confirmatory phase 3 trial in metastatic castrate-resistant prostate cancer
PRESS RELEASE MASITINIB RECEIVES FDA AND EMA AUTHORIZATION FOR CONFIRMATORY PHASE 3…